Literature DB >> 10191239

Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21).

R S Heyderman1, C A Ison, M Peakman, M Levin, N J Klein.   

Abstract

Polymorphonuclear neutrophil (PMNL) activation enhances microbial clearance but also contributes to the vascular damage and multiorgan failure associated with severe meningococcal sepsis. By use of a whole blood model of meningococcal bacteremia, loss of PMNL L-selectin and up-regulation of CD11b was observed in response to Neisseria meningitidis serogroups B and C, which is followed by opsonophagocytosis. PMNL priming with either Escherichia coli lipopolysaccharide (LPS) or FMLP prior to meningococcal challenge resulted in enhancement of both PMNL L-selectin shedding (1.5- to 4-fold) and phagocytosis (2- to 3-fold). Blockade of meningococcal LPS lipid A with recombinant bactericidal/permeability-increasing protein (rBPI21) resulted in partial inhibition of the PMNL activation and phagocytosis response to N. meningitidis. The effect of rBPI21 was reversed by excess E. coli LPS or FMLP. It is proposed that PMNL priming by N. meningitidis results in an exaggerated activation and phagocytosis response to the organism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191239     DOI: 10.1086/314706

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Elastase and granzymes during meningococcal disease in children: correlation to disease severity.

Authors:  Job B M van Woensel; Maarten H Biezeveld; C Erik Hack; Albert P Bos; Taco W Kuijpers
Journal:  Intensive Care Med       Date:  2005-07-12       Impact factor: 17.440

3.  Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.

Authors:  Jamie Findlow; Stephen Taylor; Audun Aase; Rachel Horton; Robert Heyderman; Jo Southern; Nick Andrews; Rita Barchha; Ewan Harrison; Ann Lowe; Emma Boxer; Charlotte Heaton; Paul Balmer; Ed Kaczmarski; Philipp Oster; Andrew Gorringe; Ray Borrow; Elizabeth Miller
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.

Authors:  Erika van der Maten; Marien I de Jonge; Ronald de Groot; Michiel van der Flier; Jeroen D Langereis
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

6.  Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.

Authors:  Johannes B Herrmann; Marcel Muenstermann; Lea Strobel; Alexandra Schubert-Unkmeir; Trent M Woodruff; Scott D Gray-Owen; Andreas Klos; Kay O Johswich
Journal:  mBio       Date:  2018-01-23       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.